Liquid Rolaids Featured In Line’s Re-launch Into Crowded Antacid Market
This article was originally published in The Tan Sheet
Executive Summary
Less than a year after Sanofi acquired Rolaids from Johnson & Johnson, its Chattem subsidiary reintroduces the antacid brand with tablet and liquid products in varying strengths. The liquid products could capitalize on Maalox and Mylanta missing from retail.